Back to all studies
😴
Phase 1
Sleep
in-person
PrP-targeting siRNA Safety & Mechanism Study
Sponsored by Broad Institute of MIT and Harvard
Compensation
Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
Duration
3 months
Location
Multi-State
About this study
The purpose of this trial is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic impact of PrP-siRNA in symptomatic prion disease patients.
Who can participate
- • Adults aged 18–99
- • All genders welcome
- • Diagnosed with or experiencing prion disease
- • Able to attend in-person clinic visits
What's included
- • Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Research Study?
Explore clinical trials and paid research opportunities. Compensation varies by study and is never guaranteed.